1. Home
  2. RXRX vs SAM Comparison

RXRX vs SAM Comparison

Compare RXRX & SAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RXRX
  • SAM
  • Stock Information
  • Founded
  • RXRX 2013
  • SAM 1984
  • Country
  • RXRX United States
  • SAM United States
  • Employees
  • RXRX N/A
  • SAM N/A
  • Industry
  • RXRX Biotechnology: Pharmaceutical Preparations
  • SAM Beverages (Production/Distribution)
  • Sector
  • RXRX Health Care
  • SAM Consumer Staples
  • Exchange
  • RXRX Nasdaq
  • SAM Nasdaq
  • Market Cap
  • RXRX 2.6B
  • SAM 2.7B
  • IPO Year
  • RXRX 2021
  • SAM 1995
  • Fundamental
  • Price
  • RXRX $4.33
  • SAM $242.90
  • Analyst Decision
  • RXRX Buy
  • SAM Buy
  • Analyst Count
  • RXRX 5
  • SAM 9
  • Target Price
  • RXRX $7.60
  • SAM $287.50
  • AVG Volume (30 Days)
  • RXRX 22.1M
  • SAM 158.8K
  • Earning Date
  • RXRX 05-05-2025
  • SAM 04-24-2025
  • Dividend Yield
  • RXRX N/A
  • SAM N/A
  • EPS Growth
  • RXRX N/A
  • SAM N/A
  • EPS
  • RXRX N/A
  • SAM 6.16
  • Revenue
  • RXRX $59,790,000.00
  • SAM $2,040,741,000.00
  • Revenue This Year
  • RXRX $57.30
  • SAM $2.93
  • Revenue Next Year
  • RXRX $51.53
  • SAM $2.80
  • P/E Ratio
  • RXRX N/A
  • SAM $39.72
  • Revenue Growth
  • RXRX 29.32
  • SAM 0.79
  • 52 Week Low
  • RXRX $3.79
  • SAM $215.10
  • 52 Week High
  • RXRX $12.36
  • SAM $339.77
  • Technical
  • Relative Strength Index (RSI)
  • RXRX 36.37
  • SAM 51.40
  • Support Level
  • RXRX $4.11
  • SAM $238.95
  • Resistance Level
  • RXRX $5.90
  • SAM $248.01
  • Average True Range (ATR)
  • RXRX 0.39
  • SAM 7.52
  • MACD
  • RXRX -0.11
  • SAM -0.21
  • Stochastic Oscillator
  • RXRX 11.00
  • SAM 30.20

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

About SAM Boston Beer Company Inc. (The)

Boston Beer is a top player in high-end malt beverages and adjacent categories in the us, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates over 95% of sales in the us.

Share on Social Networks: